Attention deficit-hyperactivity disorder symptoms in women with polycystic ovary syndrome

Basit Öğe Kaydı
dc.contributor.authorHerguner, Sabri
dc.contributor.authorHarmanci, Hatice
dc.contributor.authorToy, Harun
dc.date.accessioned2024-02-23T14:26:55Z
dc.date.available2024-02-23T14:26:55Z
dc.date.issued2015
dc.departmentNEÜen_US
dc.description.abstractObjectives Several studies suggest that androgens are involved in the etiology of attention deficit-hyperactivity disorder (ADHD). In this study, we investigated the ADHD symptoms in women with polycystic ovary syndrome (PCOS), a complex endocrine, hormonal, and metabolic condition associated with hyperandrogenism. Methods Forty women between the ages of 18 and 35 years with PCOS were recruited for the study group. For comparison, 40 healthy women who had regular menses were included. Current and childhood ADHD symptoms were assessed by using the Adult ADHD Self-Report Scale and Wender-Utah Rating Scale, respectively. Results Women with PCOS had higher total Adult ADHD Self-Report Scale and total Wender-Utah Rating Scale scores than controls. According to the Wender-Utah Rating Scale, the frequency of childhood ADHD was significantly higher in PCOS group than the control. Adult ADHD Self-Report Scale: Hyperactivity-Impulsivity and Wender-Utah Rating Scale: Behavioral Problems/Impulsivity scores were significantly higher in women with PCOS. However, there were no significant differences between groups in both current and childhood inattention scores. We found no correlations between ADHD symptoms and serum hormone levels including testosterone in women with PCOS. Conclusions These results suggest that women with PCOS have higher ADHD symptoms. Further studies are needed to investigate the association between PCOS and ADHD.en_US
dc.identifier.doi10.1177/0091217415610311
dc.identifier.endpage325en_US
dc.identifier.issn0091-2174
dc.identifier.issn1541-3527
dc.identifier.issue3en_US
dc.identifier.pmid26449924en_US
dc.identifier.scopus2-s2.0-84953877376en_US
dc.identifier.scopusqualityQ3en_US
dc.identifier.startpage317en_US
dc.identifier.urihttps://doi.org/10.1177/0091217415610311
dc.identifier.urihttps://hdl.handle.net/20.500.12452/14368
dc.identifier.volume50en_US
dc.identifier.wosWOS:000364964500006en_US
dc.identifier.wosqualityQ4en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.indekslendigikaynakScopusen_US
dc.indekslendigikaynakPubMeden_US
dc.language.isoenen_US
dc.publisherSage Publications Incen_US
dc.relation.ispartofInternational Journal Of Psychiatry In Medicineen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectPolycystic Ovary Syndromeen_US
dc.subjectPrenatal Androgensen_US
dc.subjectAttention Deficit-Hyperactivity Disorderen_US
dc.subjectTestosteroneen_US
dc.subjectSex Differenceen_US
dc.titleAttention deficit-hyperactivity disorder symptoms in women with polycystic ovary syndromeen_US
dc.typeArticleen_US

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu
PubMed İndeksli Yayın Koleksiyonu
Scopus İndeksli Yayınlar Koleksiyonu